Literature DB >> 10216291

X-ray crystallographic determination of the structure of the influenza C virus haemagglutinin-esterase-fusion glycoprotein.

X Zhang1, P B Rosenthal, F Formanowski, W Fitz, C H Wong, H Meier-Ewert, J J Skehel, D C Wiley.   

Abstract

The structure of the haemagglutinin-esterase-fusion (HEF) glycoprotein from influenza C virus has been determined to 3.2 A resolution by X-ray crystallography. A synthetic mercury-containing esterase inhibitor and receptor analogue, 9-acetamidosialic acid alpha-thiomethylmercuryglycoside, was designed as the single isomorphous heavy-atom derivative. The asymmetric unit of one crystal form (form I; P4322, a = b = 155.4, c = 414.4 A) contained an HEF trimer. Six mercury sites identifying the three haemagglutination and three esterase sites were located by difference Patterson map analysis of a 6.5 A resolution derivative data set. These positions defined the molecular threefold-symmetry axis of the HEF trimer. A molecular envelope was defined by averaging a 7.0 A resolution electron-density map, phased by single isomorphous replacement (SIR), about the non-crystallographic threefold-symmetry axis. Iterative non-crystallographic symmetry averaging in real space, solvent flattening and histogram matching were used to extend the phases to 3.5 A resolution. Molecular replacement of the model into a second crystal form (form II; P43212, a = b = 217.4, c = 421.4 A) containing two HEF trimers per asymmetric unit permitted iterative ninefold averaging of the electron density. The 3.5 A electron-density map allowed an unambiguous tracing of the polypeptide chain and identification of N-linked carbohydrates. The model has been refined by least squares to 3.2 A resolution (Rfree = 26.7%).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10216291      PMCID: PMC7161583          DOI: 10.1107/s0907444999000232

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


The full text for this article, hosted at http://journals.iucr.org, is unavailable due to technical difficulties.
  9 in total

1.  The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site.

Authors:  Philip R Dormitzer; Zhen-Yu J Sun; Gerhard Wagner; Stephen C Harrison
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

2.  Crystallogenesis of bacteriophage P22 tail accessory factor gp26 at acidic and neutral pH.

Authors:  Gino Cingolani; Dewan Andrews; Sherwood Casjens
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-04-28

3.  H5 avian and H9 swine influenza virus haemagglutinin structures: possible origin of influenza subtypes.

Authors:  Ya Ha; David J Stevens; John J Skehel; Don C Wiley
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

4.  Crystal structure of unliganded influenza B virus hemagglutinin.

Authors:  Qinghua Wang; Feng Cheng; Mingyang Lu; Xia Tian; Jianpeng Ma
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

Review 5.  Diversity in Rotavirus-Host Glycan Interactions: A "Sweet" Spectrum.

Authors:  Sasirekha Ramani; Liya Hu; B V Venkataram Prasad; Mary K Estes
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-03-12

Review 6.  Structure, function and evolution of the hemagglutinin-esterase proteins of corona- and toroviruses.

Authors:  Raoul J de Groot
Journal:  Glycoconj J       Date:  2006-02       Impact factor: 2.916

Review 7.  The SGNH hydrolase family: a template for carbohydrate diversity.

Authors:  Alexander C Anderson; Stefen Stangherlin; Kyle N Pimentel; Joel T Weadge; Anthony J Clarke
Journal:  Glycobiology       Date:  2022-09-19       Impact factor: 5.954

Review 8.  Hemagglutinin-esterase-fusion (HEF) protein of influenza C virus.

Authors:  Mingyang Wang; Michael Veit
Journal:  Protein Cell       Date:  2015-07-28       Impact factor: 14.870

9.  Influenza C virus and bovine coronavirus esterase reveal a similar catalytic mechanism: new insights for drug discovery.

Authors:  Juliane Mayr; Thomas Haselhorst; Martijn A Langereis; Jeffrey C Dyason; Wolfgang Huber; Barbara Frey; Reinhard Vlasak; Raoul J de Groot; Mark von Itzstein
Journal:  Glycoconj J       Date:  2008-01-15       Impact factor: 2.916

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.